
Covalent Pharma Private Limited
About Covalent Pharma Private Limited
Data last updated:
Covalent Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 30 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24304KA2019PTC129175. Its GSTIN is 29AAICC4464H1ZE (Karnataka).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹10,000. It is led by directors Avinash Kumar Chauhan and Chandresh Kumar Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #380 Gkw Layout 2nd Stg. Peenya, Bangalore, Karnataka, India – 560058.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.16 Lakh, a decline of 72% compared to the previous year. For the same year it recorded a net loss of ₹4.04 Lakh (net margin -36.1%) and EBITDA of -₹5.45 Lakh (EBITDA margin -48.9%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years.
Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Company details
Contact details
Covalent Pharma Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered Address#380 Gkw Layout 2nd Stg. Peenya, Bangalore, Karnataka, India – 560058
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Covalent Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Covalent Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Covalent Pharma Private Limited, buy the company report.
Financials of Covalent Pharma Private Limited
FY 2025 filings availableCovalent Pharma Private Limited reported revenue of ₹11.16 Lakh (down 72% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 72% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 49%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -48.9% | ||||
| Net Profit Margin | -36.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Covalent Pharma Private Limited, buy the company report.
Board of directors of Covalent Pharma Private Limited
Covalent Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avinash Kumar Chauhan Also directs: Leela Pharmaceuticals (OPC) Private Limited | Director | 30 Oct 2019 | 7 Years 0 Months | Current |
| Chandresh Kumar Gupta | Director | 30 Oct 2019 | 7 Years 0 Months | Current |
Peer comparison
Covalent Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Insist Pharmaceutical India Private Limited | ₹11.17 Lakh (FY 2017) | 36.0% | Bhopal, Madhya Pradesh, India | |||
| Festino Sales Private Limited | ₹11.17 Lakh (FY 2025) | -13.0% | Kolkata, West Bengal, India | |||
| Kidskaart India Retail Private Limited | ₹11.17 Lakh (FY 2021) | Faridabad, Haryana, India | ||||
| Myelite Cleaning Solutions Private Limited | ₹11.16 Lakh (FY 2022) | Noida, Uttar Pradesh, India | ||||
| KTS Projects Private Limited | ₹11.16 Lakh (FY 2025) | 26.0% | Belur, West Bengal, India | |||
| Covalent Pharma Private Limitedthis company | ₹11.16 Lakh (FY 2024) | -₹4.04 Lakh | -36.1% | -72.0% | Bangalore, Karnataka, India | |
| Parijat Tie-Up Pvt Ltd | ₹11.16 Lakh (FY 2025) | 154.0% | Kolkata, West Bengal, India | |||
| Balaji Grand Bazar Private Limited | ₹11.15 Lakh (FY 2025) | 4109.0% | Hyderabad, Telangana, India | |||
| Dimapur Spices Producer Company Limited | ₹11.15 Lakh (FY 2023) | 31.0% | Dimapur, Nagaland, India | |||
| Halmen Enterprises Private Limited | ₹11.15 Lakh (FY 2017) | Ernakulam, Kerala, India | ||||
| Trinity Distributors Private Limited | ₹11.15 Lakh (FY 2017) | -21.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Covalent Pharma Private Limited, buy the company report.
Legal cases
Covalent Pharma Private Limited has 2 court cases on record: 2 filed by Covalent Pharma. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Execution petition | Filed by the company against Samraksha Hospital | Pending |
| District court, BENGALURU, Karnataka | Criminal case | Filed by the company against Samraksha Hospital | Disposed |
To see the full case history of Covalent Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Covalent Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Covalent Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAICC4464H1ZE | Karnataka | Active | 19 Nov 2019 |
To see the full GST registrations and return filing status of Covalent Pharma Private Limited, buy the company report.
Recent activity
Covalent Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Avinash Kumar Chauhan was appointed as Director on 30 Oct 2019.
Frequently asked questions
Covalent Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 30 October 2019 (7+ years old) and is registered under CIN U24304KA2019PTC129175.
Covalent Pharma has 2 current directors:
- Avinash Kumar Chauhan - Director
- Chandresh Kumar Gupta - Director
The latest financial statements of Covalent Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Covalent Pharma is 29AAICC4464H1ZE, registered in Karnataka.
The CIN (Corporate Identification Number) of Covalent Pharma is U24304KA2019PTC129175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Covalent Pharma has 2 court cases on record: 2 filed by the company. 1 is pending.
Covalent Pharma was incorporated on 30 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Covalent Pharma by revenue are Insist Pharmaceutical India Private Limited, Festino Sales Private Limited, Kidskaart India Retail Private Limited, Myelite Cleaning Solutions Private Limited, KTS Projects Private Limited and 5 more, all in the same principal business activity (retail trading).
Avinash Kumar Chauhan was appointed as Director on 30 Oct 2019. Chandresh Kumar Gupta was appointed as Director on 30 Oct 2019.
The registered office of Covalent Pharma is at #380 Gkw Layout 2nd Stg. Peenya, Bangalore, Karnataka, India – 560058.
Covalent Pharma operates in the food and beverages industry, in the artificial fibres segment.

